Cohera Medical gets $16M to heal nips and tucks
Cohera Medical, a provider of wound care products and surgical adhesives, announced today that it has snagged $16.1 million in a second round of financing led by Bradford Capital Partners. Kern Whelan
and several previous investors also participated. The new money will be used to further develop the Pittsburgh company’s TissuGlu product, a sprayable adhesive tailored to plastic surgery needs, as well as several other products in the pipeline.
With tummy tucks the prime target, Cohera hopes to launch clinical trials of TissuGlu in Germany by the second quarter of next year, reports VentureWire. It is also working on adhesives appropriate for hernia surgery and bone surgery wounds.
Prior to this round, the company raised $6.8 million in August 2006, most of it coming from Kern Whelan.
Next Story: ClearCount absorbs $4M to ensure surgical sponges don’t get left behind
Previous Story: Consumer electronics survey shows darkening mood for holiday consumer spending
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.